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Background: Migraine is a complex and disabilitating neurovascular disorder predominantly affecting women.
There is strong evidence that nitric oxide is critically involved in migraine pathophysiology. The aim of the present
study was to test the hypothesis that chronic migraine is associated with ultrasonographic endothelial dysfunction
and increase in arterial stiffness. These parameters were assessed using a novel plethysmograph by peripheral
arterial tonometry.
Methods: Twenty-one patients with chronic migraine and twenty-one healthy controls matched by sex and
gender were recruited. Measurement of the ultrasonographic endothelial function and augmentation index were
made according to manufacturer’s protocol.
Results: The mean of patient’s peripheral arterial tonometry ratios was 1.93 ± 0.39 and for healthy control 2.21 ±
0.44 (p = 0.040). The median of patients’ augmentation index was −6,0 (IQR: 6.5 to −15) in healthy controls and 9.0
(IQR: 4 to 12) in chronic migraine, (p = 0.002).
Conclusions: Patients with chronic migraine have ultrasonographic endothelial dysfunction and increase in the
arterial stiffness. An improved understanding of the role in the endothelial system of migraine may provide a basis
for preventive drugs in migraine and restore the endothelial function.
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Migraine is a complex and debilitating neurovascular
disorder predominantly affecting women. It recurs as
attacks of severe headache associated with nausea,
vomiting, phonophobia, and photophobia. In some
cases, migraine headache is preceded by transient neuro-
logic symptoms that are known as aura. According to
the second edition of the International Classification of
Headache Disorders (ICHD-II) [1] chronic migraine
(CM) is defined as at least 15 days of headache per
month over the past months, of which at least eight
headache days meet the criteria for migraine without
aura or respond to migraine-specific treatment. The* Correspondence: pjimenez1010j@yahoo.es
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distribution, and reproduction in any medium,prevalence rate of CM is estimated to be 1.4% to 2.2% of
the general population [2].
Despite its high prevalence, migraine is a disease in-
volving complex pathogenetic mechanisms that remain
to be clarified [3]. However, there is strong evidence that
nitric oxide (NO) is critically involved in migraine
pathophysiology [4]. NO plays an essential role in the
control of cerebral blood flow and may be involved in
the activation of nociceptors in the trigeminovascular sys-
tem and release of vasoactive neuropeptides during neuro-
genic inflammatory response [5]. Endothelial dysfunction
is commonly described as the inability of the artery to suf-
ficiently dilate in response to an appropriate endothelial
stimulus, but also comprises endothelial activation, which
is characterized by proinflammatory and procoagulatory
milieu. By ultrasound it can be assessed by measurement
of the arterial pulse wave at a finger artery or by the meas-
urement of flow-mediated dilation (FMD) of the brachialo; licensee Springer. This is an Open Access article distributed under the terms of
p://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
provided the original work is properly cited.
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disadvantages: it is operator dependent and as FMD is
measured at one arm only, there are not possibilities to
correct for potential measurement-induced changes in the
systemic hemodynamics, such as those resulting from
alterations in the autonomous nervous system tone. To
overcome these problems, the EndoPAT was developed.
This device detects plethysmographic pressure changes in
the finger tips caused by the arterial pulse and translates
this to a peripheral arterial tone (PAT). Endothelium-
mediated changes in vascular tone after occlusion of the
brachial artery are reflecting a downstream hyperemic re-
sponse, which is measure for arterial endothelial function
[6]. Measurements on the contralateral arm are used to
control for concurrent nonendothelium-dependent changes
in vascular tone. In addition, the EndoPAT provides a
measure for arterial stiffness: the augmentation index (AI).
Several EndoPAT studies have demonstrated an improve-
ment in ultrasonographic endothelial function as a result
of lifestyle modification [7] or prolonged pharmacological
intervention [8].
The aim of the present study was to test the hypoth-
esis that chronic migraine is associated with ultrasono-
graphic endothelial dysfunction and an increase in arterial
stiffness using a novel non-invasive peripheral finger ple-
thysmograph (EndoPAT). We study the chronic migraines
because is probably than the changes in the ultrasono-
graphic endothelial dysfunction were more important and
persistent than in episodic migraines.
Methods
Study population
Patients with CM were consecutively recruited from the
outpatient headache clinic between May 2009 and Sep-
tember 2010. Twenty-one patients with CM who ful-
filled the diagnostic criteria of CM according to the
ICHD-II were included. All patients had detailed clinical
evaluation and a structured interview about history of
headache by an experienced neurologist. Twenty-one
healthy participants were recruited from volunteers
among the staff of the hospital and served as control
group. Healthy volunteers without history of migraine
were matched with patients by sex and age. Exclusion
criteria were age < 18 and ≥ 50 years, body mass index
(BMI) < 18 and ≥ 30 kg/m2, history of cardiovascular dis-
ease, Raynaud syndrome, peripheral vascular disease, in-
flammatory conditions, active cancer, ovarium pathology,
smoking, arterial hypertension (systolic blood pressure >
140 mmHg or diastolic blood pressure > 90 mmHg), dia-
betes mellitus (fasting plasma glucose ≥ 126 mg/dl), hyper-
cholesterolemia (> 220 mg/dl), pregnancy or lactation and
regular use of vasoactive drugs. Sporadic consumptions of
vasoactive drugs for more than a week before the test were
allowed. We reject to make the EndoPAT test in subjectwith morphologic defects or finger wounds. Carotid
intima-media thickness (IMT) was measured in patients
and controls. The first author made the interviews and the
test, so he was not blinded to the patient or control sub-
jects. The hospital Ethics Committee approved the study
protocol and all patients gave informed consent.
Study protocol
Reactive hyperaemia index (RHI), which is a measure of
endothelial function, and augmentation index (AI), which
is a measure for arterial stiffness, were assessed using
the EndoPAT 2000 device (Itamar, Israel). AI is the dif-
ference between the first and the second peaks of the ar-
terial waveform. Values are expressed as a percentage of
the central pulse pressure. In addition, because AI is
influenced by changes in heart rate, all values of AI were
corrected to 75 beats per minute (AI@75 bpm) [9]. As-
sessment of the ultrasonographic endothelial function
was based on the measurement of peripheral arterial
tonometry (PAT) of the index finger during reactive
hyperaemic of the forearm vascular bed as previously
described [6]. All measures were calculated using a
computerised automated algorithm provided with the
device. Measurements were performed according to
manufacturer’s instructions [10]. Briefly, the subjects
were in supine position for a minimum of 20 minutes
before measurements, in a quiet, temperature-controlled
(21-24°C) room with dimmed lights. The subjects were
asked to remain as still as possible and silent during
the entire measurement period. Each recording con-
sisted of 5 minutes of baseline measurement, 5 minutes
of occlusion measurement, and 5 minutes postocclu-
sion measurement (hyperaemic period) as is showed in
the Figure 1. Occlusion of the brachial artery was
performed on the nondominant upper arm. The occlu-
sion pressure was at least 60 mmHg above the systolic
blood pressure (minimally 200 mmHg, and maximally
300 mmHg).
IMT was defined according to the Mannheim Consen-
sus as the distance between the characteristic echoes of
the lumen-intima interface and the media-adventitia
interface for both sides.
Statistical analysis
Sample size estimation was based on a previous study
that investigated differences in endothelial-dependent
FMD between migraine and healthy controls [11], an
alpha error of 0.05 and a power of the test of the 80%.
We check the sample for a normal distribution of
observed RHI and AI values. Data are expressed as
mean ± SD or median and interquartile range (IQR) for
continuous variables and as frequencies and propor-
tions for categorical variables. Continuous data from
the two groups were compared using properly the
Figure 1 Representative peripheral arterial tonometry recordings of reactive hyperaemic response after 5 minutes of occlusion of the
braquial artery.
Jiménez Caballero and Muñoz Escudero The Journal of Headache and Pain 2013, 14:8 Page 3 of 6
http://www.thejournalofheadacheandpain.com/content/14/1/8Mann–Whitney U-test or unpaired t-test. For correl-
ation the Spearman rank correlation was used. All tests
were two-tailed, and statistical significance was deter-
mined at an alpha level of 0.05. Statistical analyses were
performed using SPSS version 15.0.Figure 2 Blox-plot that shows the differences in the RHI (expressed aResults
Twenty-one patients with CM were enrolled in this
study. 6 of them were males (28.5%) and 15 were
females (71.4%). The number of days per month with
headache was 21.4 ± 5.2. The mean of patients’ age wass ratios) between chronic migraine patients and healthy controls.
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healthy control was 36.29 ± 6.83 (p: 0.914). The mean of
patients’ BMI was 24.52 ± 2.31 and for healthy control
was 23.76 ± 2.54 (p = 0.514). The mean of patients’ IMT
was 0.68 ± 0.008 and for healthy control was 0.69 ± 0.007
(p = 0.712). The mean of patients’ PAT ratios was 1.93 ±
0.39 and for healthy control 2.21 ± 0.44 (p = 0.040)
(Figure 2). The median of patients’ heart-rate-average AI
[median and IQR] was of −6.0 (IQR: 8.5 to −17) in
healthy controls and 9.0 (IQR: 4 to 12) in chronic mi-
graine, (p = 0.002) (Figure 3). The median of patients’
heart-rate-adjusted AI@75 was −3.0 (IQR: 10 to −18) in
healthy controls and 8.0 (IQR: 5.5 to 14.5) in chronic
migraine, (p = 0.004).
There were not differences in the RHI by gender:
females 2.08 ± 0.47 and males 2.05 ± 0.35 (p = 0.870).
There was not correlation between RHI and age (R =
−0.132, p = 0.405) or BMI (R = +0.126, p = 0.412).
There was not differences in the AI by gender: females
−4 (IQR: 5 to −16) and males −7 (IQR: 12 to −21) (p =
0.253). There were not correlation between AI and age (R =
−0.055, p = 0.727), number of days with headache (R =
+0.073; p = 0.628) or BMI (R = +0.187, p = 0.235). There
were not correlation between RHI and number of days per
month with headache (R:-0,218; p = 0.083). There was a
negative correlation between RHI and heart-rate-average AI
(R =−0.377, p = 0.014).
Discussion
Our study shows the following findings: 1) AI as an in-
direct marker for arterial stiffness is increased in patientsFigure 3 Box-plot that shows the differences in the AI (expressed as
healthy controls.with CM compared with matched healthy controls; and
2) patients with CM have worse ultrasonographic endo-
thelial function using digital reactive hyperaemic periph-
eral arterial tonometry.
Evidence of endothelial dysfunction in migraine is in-
creasing. Migraine is associated with reduction in the
number and function of endothelial progenitor cells,
serving as a marker for dysfunction of the endothelium
[12] and its counts decrease as migraine progresses in
time [13]. In this same study didn’t found differences in
the FMD between patients with and healthy control.
They suggest a relation with the intensity of headaches
more than its frequency.
Some migraine patients could to have an arterial
super-sensitivity to NO [14] may be explained by an
autonomic dysfunction. Some authors [15] reported a
possible impairment of sympathetic control of cerebral
blood flow in migraine patients.
Previous studies have already investigated the ultra-
sonographic endothelial function and NO vascular re-
sponse describing a normal [16-18], reduced [19,20] or
increased FMD [21] in migraine patients respect to con-
trols. However, two studies evaluated only patients
affected by migraine without aura [18,19], and two stud-
ies did not distinguish between migraine with aura or
without aura in their analytic approach [16,20].
A recent study using EndoPAT device did not find
evidence for systemic endothelial dysfunction in mi-
graine with aura patients [22]. The mean of attacks per
month was 3.2. In the same study, the authors found an
augmentation in the arterial stiffness measured by AI.percentages) between chronic migraine patients and
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per month respect to our study could determinate the
lack of alteration in the ultrasonographic endothelial
function.
Endothelial function as measured by the EndoPAT
could be physiologically different from endothelial func-
tion as measured by the conventional techniques [23].
Onkelinx et al. [24] studied the reproducibility of differ-
ent methods to measure the endothelial function and
found that the within-day variability was lower for the
FMD measurements than for the PAT measurements,
but the between-day variability was similar.
Some studies [25,26] have shown that patients with
migraine have higher IMT than healthy controls and
suggest that migraine could be a risk factor for athero-
sclerosis, but our study don’t found differences. Malik
et al. [27] have shown in healthy controls a negative cor-
relation between vascular reactivity and arterial stiffness.
Our too have shown this relation in patients with CM.
There are some reports indicating association with mi-
graine and other vascular related situations. Prevalence of
migraine has been found to be higher in patients with
vasospastic angina than in controls [28]. Miller et al. [29]
reported that the prevalence of migraine was 26% in 62
patients with variant angina, which was higher than that in
a coronary control group (6%). Smyth et al. [30] reported
than patients with primary Raynoud’s phenomenon, there
is a higher personal history of migraine than in controls.
Nagai et al. [31] have found that migraine is associated
with enhanced arterial stiffness.
Our study has several limitations. Firstly, AI is not a
direct measure of arterial stiffness. It has been suggested
that arterial stiffness and augmented pressure from wave
reflexions significantly contribute to the digital volume
pulse inflection point; however, AI is influenced by several
other factors, such as gender differences in vascular geom-
etry, peripheral resistance, height, and pulse wave velocity.
Secondly, for practical reasons, the investigator who per-
formed the measurements was not blinded to the subjects’
history. However, all on-line measurements were com-
pletely automated and off-line calculations and analyses
were performed blinded after encoding the original files.
Thirdly, given the small sample size in our study, our find-
ings and its generalizability have to be interpreted with
caution, and further evidence from larger observational
studies is needed. Finally, we did not report data from the
presence or not of headache during the realization of the
probe, sporadic consumptions of vasoactive drugs for
more than a week before the test and neither from the
duration of the disease. These data could be important to
understand the endothelial function in migraine.
One study revelled that Enalapril can possibly improve
endothelial function [32]. An improved understanding of
the role in the endothelial system of migraine may providea basis for preventive drugs in migraine [33] and restore
the endothelial function.
Conclusions
Patients with chronic migraine habe ultrasonographic
endothelial dysfunction and increase in the arterial stiff-
ness. An improved understanding of the role in the
endothelial system of migraine may provide a basis for
preventive drugs in migraine and restore the endothelial
function.
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